Type 2 Diabetes

In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...

From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...

In part 2 of this interview, Estelle Everett, MD, addresses the shortage of endocrinologists from underserved communities and highlights strategies to build a more diverse health care workforce. She also...

In part 1 of this interview, Estelle Everett, MD, explores the impact of provider bias and clinic barriers on access to diabetes technology. She shares how improving access to tools like continuous glucose...

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...

In part 2 of this interview, Estelle Everett, MD, addresses the shortage of endocrinologists from underserved communities and highlights strategies to build a more diverse healthcare workforce. She also...